Radiation Therapy in Burkitt Lymphoma
Burkitt lymphoma (BL) is a highly aggressive non-Hodgkin lymphoma revealing one of the highest proliferation rates in malignancies. Its frequent extranodal involvement and possible generalization to an acute leukemia challenge effective treatment which normally consists of a poly-agent chemotherapy. The following chapter sheds light on epidemiology, tumor biology, treatment options and prognosis of this lymphoma which has evolved from an enigmatic syndrome to a curable disease.
KeywordsLymphoma Burkitt Agressive Stem cell Transplantation CNS
- Jourdain A, Auperin A, Minard-Colin V, et al. Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective “Lymphomes Malins B” protocols. A Société Française des Cancers de l’Enfant study. Haematologica. 2015;100:810–7. https://doi.org/10.3324/haematol.2014.121434.CrossRefPubMedPubMedCentralGoogle Scholar
- Lee EJ, Petroni GR, Schiffer CA, et al. Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. J Clin Oncol Off J Am Soc Clin Oncol. 2001;19:4014–22. https://doi.org/10.1200/JCO.2001.19.20.4014.CrossRefGoogle Scholar
- Maramattom LV, Hari PN, Burns LJ, et al. Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2013;19:173–9. https://doi.org/10.1016/j.bbmt.2012.11.016.CrossRefGoogle Scholar
- Mead GM, Barrans SL, Qian W, et al. A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). Blood. 2008;112:2248–60. https://doi.org/10.1182/blood-2008-03-145128.CrossRefPubMedPubMedCentralGoogle Scholar
- World Health Organization (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th edition. International Agency for Research on Cancer, Lyon.Google Scholar